Doxorubicin-melphalan with and without cisplatin in advanced ovarian cancer--ten-year survival results from a prospective randomized study by the Swedish Cooperative Ovarian Cancer Study Group.
暂无分享，去创建一个
C. Tropé | T. Högberg | U. Stendahl | H. Andersson | G. Horvath | B. Sorbe | H. Persson | M. Ryberg | E. Simonsen | E. Björkholm | B. Frankendal | A. Himmelman | B. Westholm | B. Petterson